DOT has released an update on its new transport proteins for vehicle-borne disease (TB) that would require transportation carriers to use them to control the spread of TB.

The DOT announced the updates on Thursday, following a request from the Federal Aviation Administration (FAA) and the Department of Transportation (DOT).

According to the DOT, the update would require carriers to “use transport proteins that contain a protective cap” for TB transmission.

The cap is made of a thin, flexible polymer that absorbs and dissipates airborne particles.

This allows the transport protein to absorb and disperse airborne particles in a way that makes them more difficult for the bacteria to carry.

As of April, the DOT estimated that about 6.4 million Americans have been diagnosed with TB.

The new updates are designed to help transport carriers improve the effectiveness of the proteins.

The DOT said the new update would also improve the performance of the transportation proteins for the transportation of people, goods, and cargo.

The final DOT-DOT update on the new transport protein was issued last week.

The agency did not provide any details about the changes.

The agency’s TB-related research and development is supported by a variety of federal and private sources, including the U.S. Department of Defense and the National Institutes of Health.